Sangamo Therapeutics maintains its corporate headquarters and primary research laboratories in Richmond, California. Situated in the San Francisco Bay Area biotechnology corridor, the company utilizes its regional footprint to advance genomic medicine, cell therapies, and zinc finger gene editing technologies targeting severe genetic disorders.